CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity

被引:41
作者
Takahashi, Michiko
Takahashi, Yutaka
Takahashi, Kenichi
Zolotaryov, Fyodor N.
Hong, Kyoung Su
Iida, Keiji
Okimura, Yasuhiko
Kaji, Hidesuke
Chihara, Kazuo
机构
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Kobe, Hyogo 6500017, Japan
[2] JCR Pharmaceut Co Ltd, Res Affairs Ctr, Div Res, Nishi Ku, Kobe, Hyogo 6512241, Japan
[3] Kobe Univ, Sch Med, Dept Basic Allied Med, Kobe, Hyogo 6540142, Japan
[4] Univ Hyogo, Div Physiol Metab, Akashi, Hyogo 6738588, Japan
关键词
CXCL14; BRAK; obesity; insulin; sensitivity; inflammation; high-fat diet; 3T3-L1; adipocyte; chemokine;
D O I
10.1016/j.bbrc.2007.10.120
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulating evidence suggests an association between obesity and adipose tissue inflammation. Chemokines are involved in the regulation of inflammation status. Chemokine (C-X-C motif) ligand 14 (CXCL14) is known to be a chemoattractant for monocyte and dendritic cells. Recently, it was reported that CXCL14-deficient mice show resistance to high-fat diet-induced obesity. In this study, we identified CXCL14 as a growth hormone (GH)-induced gene in HepG2 hepatoma cells. Substantial in vivo expression of CXCL14 was detected in the adipose tissue and liver. Its expression and secretion were strikingly increased by insulin administration and high-fat diet. Intriguingly, incubation of 3T3-L1 adipocytes with CXCL14 stimulated insulin-dependent glucose uptake. Further, this effect was associated with enhanced insulin signaling. CXCL14 enhanced the insulin-induced tyrosine phosphorylation of insulin receptors and insulin receptor substrate-1. These results suggest that CXCL14 plays a causal role in high-fat diet-induced obesity. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1037 / 1042
页数:6
相关论文
共 28 条
[1]   Growth hormone deficiency and cardiovascular risk [J].
Best, JD ;
O'Neal, D ;
Kamarudin, N ;
Alford, FP ;
Best, JD .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1998, 12 (02) :199-216
[2]   Chemokines in the pathogenesis of vascular disease [J].
Charo, IF ;
Taubman, MB .
CIRCULATION RESEARCH, 2004, 95 (09) :858-866
[3]   Adipose tissue, adipokines, and inflammation [J].
Fantuzzi, G .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (05) :911-919
[4]   Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells [J].
Hromas, R ;
Broxmeyer, HE ;
Kim, C ;
Nakshatri, H ;
Christopherson, K ;
Azam, M ;
Hou, YH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (03) :703-706
[5]  
Johannsson G., 1999, Journal of Endocrinological Investigation, V22, P41
[6]   Adipose tissue as an endocrine organ [J].
Kershaw, EE ;
Flier, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2548-2556
[7]   NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice [J].
Kojima, H ;
Fujimiya, M ;
Matsumura, K ;
Younan, P ;
Imaeda, H ;
Maeda, M ;
Chan, L .
NATURE MEDICINE, 2003, 9 (05) :596-603
[8]   Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development [J].
Kurth, I ;
Willimann, K ;
Schaerli, P ;
Hunziker, T ;
Clark-Lewis, I ;
Moser, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) :855-861
[9]   Macrophages, inflammation, and atherosclerosis [J].
Linton, MF ;
Fazio, S .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (Suppl 3) :S35-S40
[10]  
Maebayashi Y, 1999, J NEUROSCI, V19, P10176